SCHEMBL25825412

SCHEMBL25825412

O=C(Nc1ccc(Nc2ccccc2)cc1)c1ccc(Nc2ccnc3ccc(F)cc23)nc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 8/20 0.55
DNMT3A Q9Y6K1 7/20 0.55
DNMT3L Q9UJW3 4/20 0.55
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
POLB P06746 1/20 0.51
USP2 O75604 1/20 0.49
MAPT P10636 1/20 0.49
AURKA O14965 4/20 0.48
AURKB Q96GD4 4/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
CCNC P24863 1/20 0.47
CDK8 P49336 1/20 0.47
EHMT1 Q9H9B1 2/20 0.47
MYC P01106 1/20 0.47
MAP2K3 P46734 1/20 0.47
EHMT2 Q96KQ7 1/20 0.47
DNMT3B Q9UBC3 1/20 0.47
CXCR1 P25024 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19151411 0.92 KMT2A (0.59) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL30180798 0.92 KMT2A (0.59) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL25825409 0.90 DNMT1 (0.57) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL23999712 0.90 DNMT1 (0.69) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL24003808 0.89 DNMT1 (0.52) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL25825406 0.87 DNMT1 (0.53) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL25826601 0.87 DNMT1 (0.53) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL25825374 0.86 DNMT1 (0.53) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL25826583 0.86 DNMT1 (0.53) DNMT1DNMT3ADNMT3LKMT2AMEN1
SCHEMBL25825372 0.85 KMT2A (0.70) DNMT1DNMT3ADNMT3LKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR DNMT1 4785/4885DNMT3A 4693/4885DNMT3L 4461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.